NF-kappa-B activation unveils the presence of inflammatory hotspots in human gut xenografts.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2021
Historique:
received: 17 11 2020
accepted: 17 03 2021
entrez: 3 5 2021
pubmed: 4 5 2021
medline: 8 10 2021
Statut: epublish

Résumé

The single-epithelial cell layer of the gut mucosa serves as an essential barrier between the host and luminal microflora and plays a major role in innate immunity against invading pathogens. Nuclear factor kB (NF-κB), a central component of the cellular signaling machinery, regulates immune response and inflammation. NF-κB proteins are activated by signaling pathways downstream to microbial recognition receptors and cytokines receptors. Highly regulated NF-κB activity in intestinal epithelial cells (IEC) is essential for normal gut homeostasis; dysregulated activity has been linked to a number of disease states, including inflammatory bowel diseases (IBD) such as Crohn's Disease (CD). Our aim was to visualize and quantify spatial and temporal dynamics of NF-κB activity in steady state and inflamed human gut. Lentivirus technology was used to transduce the IEC of human gut xenografts in SCID mice with a NF-κB luminescence reporter system. NF-κB signaling was visualized and quantified using low resolution, intravital imaging of the whole body and high resolution, immunofluorescence microscopic imaging of the tissues. We show that NF-κB is activated in select subset of IEC with low "leaky" NF-κB activity. These unique inflammatory epithelial cells are clustered in the gut into discrete hotspots of NF-κB activity that are visible in steady state and selectively activated by systemic LPS and human TNFα or luminal bacteria. The presence of inflammatory hotspots in the normal and inflamed gut might explain the patchy mucosal lesions characterizing CD and thus could have important implications for diagnosis and therapy.

Identifiants

pubmed: 33939711
doi: 10.1371/journal.pone.0243010
pii: PONE-D-20-36116
pmc: PMC8092666
doi:

Substances chimiques

Lipopolysaccharides 0
NF-kappa B 0
Tumor Necrosis Factor-alpha 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243010

Déclaration de conflit d'intérêts

The authors have no conflict of interest to declare.

Références

Blood. 2014 Aug 21;124(8):1203-4
pubmed: 25147372
Curr Opin Virol. 2015 Apr;11:14-20
pubmed: 25618248
J Biol Chem. 1998 Dec 25;273(52):34970-5
pubmed: 9857028
Nat Immunol. 2019 Mar;20(3):301-312
pubmed: 30664737
Nat Methods. 2008 Oct;5(10):877-9
pubmed: 18806792
Sci Transl Med. 2019 May 22;11(493):
pubmed: 31118293
J Intern Med. 2008 Jun;263(6):591-6
pubmed: 18479258
Science. 2011 Apr 22;332(6028):472-4
pubmed: 21415320
Gastroenterology. 1991 Jan;100(1):89-98
pubmed: 1983853
Pediatr Res. 2001 Aug;50(2):196-202
pubmed: 11477203
J Clin Invest. 1989 Sep;84(3):847-56
pubmed: 2760216
EMBO J. 2011 Jan 5;30(1):221-31
pubmed: 21113130
Vet Immunol Immunopathol. 2013 Mar 15;152(1-2):168-75
pubmed: 23073139
Infect Immun. 2017 Oct 18;85(11):
pubmed: 28784929
Gastroenterology. 2011 Jul;141(1):197-207
pubmed: 21439961
J Immunol. 2004 Aug 1;173(3):1561-70
pubmed: 15265883
Nat Methods. 2014 Apr;11(4):393-5
pubmed: 24509630
Nat Commun. 2016 Jul 06;7:12057
pubmed: 27381163
Nat Biotechnol. 2019 Oct;37(10):1163-1173
pubmed: 31451733
Cell Microbiol. 2012 Jun;14(6):840-51
pubmed: 22288381
Curr Opin Chem Biol. 2010 Feb;14(1):80-9
pubmed: 19962933
J Infect Dis. 2009 Feb 1;199(3):350-4
pubmed: 19133807
J Immunol. 2007 May 15;178(10):6522-32
pubmed: 17475882
Blood. 2014 Feb 27;123(9):1422-4
pubmed: 24578496
Cell. 2017 Jan 12;168(1-2):37-57
pubmed: 28086098
Sci Transl Med. 2014 Oct 15;6(258):258ra143
pubmed: 25320235
J Exp Med. 2010 Jul 5;207(7):1513-23
pubmed: 20530205
J Exp Med. 2018 May 7;215(5):1383-1396
pubmed: 29511064
Sci Transl Med. 2015 Feb 25;7(276):276ra25
pubmed: 25717098
Vet J. 2016 Jan;207:180-183
pubmed: 26626090
Blood. 2014 Aug 21;124(8):1221-31
pubmed: 24951430
Dev Cell. 2019 Nov 4;51(3):357-373.e5
pubmed: 31607651
J Immunol. 2014 May 15;192(10):4636-47
pubmed: 24740501
F1000Res. 2019 Jan 18;8:
pubmed: 30705753
Am J Physiol Heart Circ Physiol. 2013 Mar 15;304(6):H874-84
pubmed: 23335792
Nat Rev Gastroenterol Hepatol. 2019 Jan;16(1):19-34
pubmed: 30429586
Endocrinology. 2019 Apr 1;160(4):744-758
pubmed: 30566603
Dis Model Mech. 2011 Jan;4(1):86-94
pubmed: 20959635
J Immunol. 2002 Feb 1;168(3):1441-6
pubmed: 11801687
Atherosclerosis. 2013 Apr;227(2):297-306
pubmed: 23422832
Immunity. 2019 Feb 19;50(2):462-476.e8
pubmed: 30770246
Gut. 2016 Apr;65(4):584-94
pubmed: 25715355
Gastroenterology. 2018 Feb;154(3):585-598
pubmed: 29031501
J Crohns Colitis. 2019 May 27;13(6):798-806
pubmed: 30590414
J Immunol. 2017 Oct 15;199(8):2652-2667
pubmed: 28904128
Gastroenterology. 2019 May;156(6):1775-1787
pubmed: 30710527
J Cell Biol. 1990 Aug;111(2):347-59
pubmed: 2199454
Dis Model Mech. 2013 Nov;6(6):1388-99
pubmed: 24046352
Cell Death Differ. 2016 Sep 1;23(9):1565-76
pubmed: 27177019
J Clin Invest. 2013 Jun;123(6):2590-603
pubmed: 23676465
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
J Exp Med. 2011 Aug 29;208(9):1889-900
pubmed: 21825016
Neurogastroenterol Motil. 2018 Mar;30(3):
pubmed: 28884943
Proc Natl Acad Sci U S A. 2013 Apr 30;110(18):7306-11
pubmed: 23589850
Vet Res. 2020 Jun 15;51(1):77
pubmed: 32539761
Differentiation. 1995 Jun;58(5):361-71
pubmed: 7622011
Brain Pathol. 2012 Jul;22(4):499-510
pubmed: 22059637
Am J Physiol Renal Physiol. 2007 Sep;293(3):F680-7
pubmed: 17634396
J Pathol. 2020 Jun;251(2):160-174
pubmed: 32222043
Integr Biol (Camb). 2015 Jun;7(6):713-25
pubmed: 25990200

Auteurs

Einat Nissim-Eliraz (E)

Department of Basic Sciences, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.

Eilam Nir (E)

Department of Basic Sciences, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.

Noga Marsiano (N)

Department of Basic Sciences, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.

Simcha Yagel (S)

Department of Obstetrics and Gynecology, Hadassah University Hospital, Jerusalem, Israel.

Nahum Y Shpigel (NY)

Department of Basic Sciences, Koret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH